DENIENE KING: Open Payments
NPI 1093107948 · OAK PARK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,007 in 134 payments from 13 companies in 2025. Trend: 2023 $2,243 · 2024 $4,132 · 2025 $5,007
Food & beverage: $4,794Education: $213
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 38 | $1,165 |
| Teva Pharmaceuticals USA, Inc. | 13 | $899 |
| Otsuka America Pharmaceutical, Inc. | 26 | $617 |
| Alkermes, Inc. | 9 | $496 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $412 |
| ABBVIE INC. | 15 | $316 |
| Neurocrine BioSciences, Inc. | 9 | $287 |
| Braeburn Inc. | 2 | $234 |
| Lundbeck LLC | 8 | $196 |
| Axsome Therapeutics, Inc. | 4 | $180 |
Products named: COBENFY, REXULTI, CAPLYTA, UZEDY, AUSTEDO XR, VRAYLAR, INGREZZA, LYBALVI.
Industry payments across MI — which companies pay providers there.
